Fundamental dimension Equity attribute | GMEDLeader $81.41▼-0.31% Cap $10.93BP/E 20.5x QuantScore75/100 | ATECPeer $11.11▼-2.20% Cap $1.72BP/E -15.4x QuantScore60/100 | BVSPeer $14.96▼-0.53% Cap $1.02BP/E 18.6x QuantScore62/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
75/100 |
88/100 |
83/100 |
Valuation Multiples, PEG & DCF upside | 74/100 | 18/100 | 75/100 |
Health Piotroski, Altman Z, leverage & liquidity | 96/100 | 43/100 | 43/100 |
Growth Revenue / earnings growth & margins | 75/100 | 69/100 | 48/100 |
Sentiment Analyst ratings, targets & revisions | 58/100 | 81/100 | 61/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 20.5x | -15.4x | 18.6x |
Forward P/E (next FY) | 16.3x | 34.0x | 19.2x |
EV / EBITDA (TTM) | 11.1x | 163.6x | 12.1x |
Price / Sales | 3.5x | 2.1x | 1.8x |
Price / Free Cash Flow | 14.6x | 412.9x | 10.8x |
PEG ratio | 0.40 | -0.31 | 0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 5 / 9 | 8 / 9 |
Altman Z-Score | 10.85 (Safe) | -0.28 (Distress) | 2.27 (Grey) |
Total debt / equity | 0.02 | -50.05 | 1.16 |
Quick ratio | 2.9x | 1.1x | 1.2x |
Interest coverage | — | -1.1x | 3.1x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +16.7% | +25.0% | -0.9% |
Net income growth YoY | +422.3% | +11.6% | +167.8% |
Gross margin (TTM) | 68.5% | 66.1% | 68.0% |
Operating margin (FY) | 16.3% | -10.7% | 10.3% |
FCF margin (FY) | 20.0% | 0.4% | 12.6% |
5. Trailing price performancePrice change over period |
1M return | +9.6% | +12.0% | +10.7% |
3M return | +6.4% | +34.5% | +26.8% |
6M return | -14.2% | +1.9% | +48.3% |
Year to date | -6.8% | -47.2% | +101.1% |
1Y return | +30.7% | -31.0% | +115.6% |
3Y return | +65.2% | -13.3% | +366.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $49.72 -38.9% premium | $12.29 +10.6% upside | $-2.67 -117.8% premium |
Wall Street consensus target | $95.13 +16.9% · range $80.00–$117.00 | $16.22 +46.0% · range $12.00–$24.00 | $18.33 +22.5% · range $18.00–$19.00 |
Consensus stance | 72% Buy25% Hold3% Sell | 85% Buy10% Hold5% Sell | 71% Buy29% Hold0% Sell |